ReviewFrontiers in pharmacology2014

N-acetyl-seryl-aspartyl-lysyl-proline: a valuable endogenous anti-fibrotic peptide for combating kidney fibrosis in diabetes.

Keizo Kanasaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.